Additionally, the HR for high ABCD3 expression on DSS of GBM patients was 1.71 (95% CI, 1.32 to 2.22; P < 0.001), and that of LGG patients was 1.65 (95% CI, 1.14 to 2.37; P = 0.008) (Figures 3B–E). Here, ABCD3 is linked to glioblastoma.